ARDX

Ardelyx Inc.

Price

$4.03

return (12m)

-31.23%

p/e

-17.85

p/bv

6.67

DIVIDEND YIELD

0.00%

ARDX price

Ardelyx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARDX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.72%

3 months

-36.54%

1 year

-31.23%

2 years

-32.72%

5 years

200.75%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ARDX

Valuation

P/E

-17.85

Sector -4.38

Industry -4.38

P/BV

6.67

Sector 2.02

Industry 2.02

P/Revenue (PSR)

2.21

Sector -4.40

Industry -4.40

EV/EBITDA

-98.62

Sector -263.09

Industry -263.09

EV/EBIT

-92.83

Sector -702.90

Industry -702.90

P/EBITDA

-42.44

Sector -4.39

Industry -4.39

P/EBIT

-37.15

Sector -4.73

Industry -4.73

P/Total Assets

1.73

Sector 1.49

Industry 1.49

P/Net Current Assets

66.08

Sector -11.70

Industry -11.70

P/Working Capital

3.21

Sector -3.19

Industry -3.19

EPS

-0.22

Sector -2.14

Industry -2.14

BVPS

0.60

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

94.37%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-8.09%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-8.60%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-7.86%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-12.35%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.21

Sector 0.03

Industry 0.03

Profitability

ROE

-37.38%

Sector -65.14%

Industry -65.14%

ROA

-9.67%

Sector -65.53%

Industry -65.53%

ROIC

-27.95%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.34

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.07

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.89

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.20

Sector -1.07

Industry -1.07

Gross Debt / Equity

1.69

Sector -0.05

Industry -0.05

Equity/Assets

0.26

Sector 0.41

Industry 0.41

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

113.81%

Sector -

Industry -

5Y Earnings CAGR

-18.84%

Sector -

Industry -

Fundamentals ARDX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARDX Ardelyx Inc.	$4.03	-30.64%	0.00%	-17.85	6.67	-37.38%	-12.35%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARDX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ardelyx

Ardelyx Inc.

Average Investor10 user rating

4.0 (1 people)

United States

19 years

Founded: 2007

2014

Time since IPO - 12 years

129

Employees

Ardelyx Inc. (United States) is listed on the Nasdaq and has a market capitalization of $994.48 million, with shareholders equity totaling $149.01 million.

The company employs approximately 129 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ardelyx Inc. reported $450.90 million in revenue, generating net income of $-55.70 million.

Key financial metrics include a P/E ratio of -17.85, a price-to-book (P/B) ratio of 6.67, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARDX.

Market cap

$994.48 million

Net worth

$149.01 million

$149,010,000.00

Assets

$575.89 million

$575,890,000.00

Total Shares Outstanding

248.00 million

248,000,000

Average Daily Trading Volume

$4.37 million

$4,367,676.00

Sector

Health Care

Industry

Biotechnology

ARDX

ARDX revenue and profits

Financial Results ARDX

DRAG THE FRAME TO SEE MORE DATA

ARDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Ardelyx (ARDX) today?

A cotação de Ardelyx (ARDX) hoje está em US$ 4.03, com uma variação de -31.23% em relação ao último ano. A cotação de Ardelyx (ARDX) iniciou o ano negociando na casa dos US$ 5.83 e hoje está em US$ 4.03. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ardelyx (ARDX) e dados de ações do Ibovespa e mercados internacionais.

Quando Ardelyx (ARDX) paga dividendos?

Ardelyx (ARDX) não distribuiu dividendos no último ano.

Is Ardelyx (ARDX) a good investment?

Atualmente, Ardelyx (ARDX) está cotada a US$ 4.03, com um P/L de -17.85, representando um desvio de -2,051% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -31.23 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -31.23%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ardelyx (ARDX) stock?

Investir em ações de Ardelyx (ARDX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ardelyx (ARDX) yield today?

A rentabilidade de Ardelyx (ARDX) foi de -19.72% no último mês, -31.23% no último ano e 200.75% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ardelyx (ARDX) hoje, o investimento total seria de US$ 403.00, com base na cotação atual de US$ 4.03.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 277.14
Em 5 anos: US$ 1,212.02
Em 10 anos: US$ 403.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARDX

Ardelyx Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARDX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ARDX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ardelyx

Ardelyx Inc.

United States

19 years

2014

129

PROFIT X PRICE ARDX

Financial Results ARDX

ARDX cash flow

Asset, Revenue and Profit Growth - ARDX

ARDX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions